Schneider Downs Wealth Management Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-25,000
Closed -$13K 77
2019
Q2
$13K Hold
25,000
﹤0.01% 72
2019
Q1
$11K Hold
25,000
﹤0.01% 67
2018
Q4
$12K Hold
25,000
0.01% 66
2018
Q3
$13K Hold
25,000
0.01% 56
2018
Q2
$13K Hold
25,000
0.01% 53
2018
Q1
$11K Hold
25,000
0.01% 54
2017
Q4
$10K Hold
25,000
0.01% 45
2017
Q3
$9K Hold
25,000
0.01% 42
2017
Q2
$10K Hold
25,000
0.01% 45
2017
Q1
$11K Hold
25,000
0.01% 46
2016
Q4
$10K Hold
25,000
0.01% 30
2016
Q3
$7K Hold
25,000
﹤0.01% 32
2016
Q2
$6K Hold
25,000
﹤0.01% 28
2016
Q1
$3K Hold
25,000
﹤0.01% 27
2015
Q4
$3K Buy
+25,000
New +$3.53K ﹤0.01% 27

Other funds holding GCVRZ

Schneider Downs Wealth Management Advisors's GCVRZ Position: Q3 2019 in Review

Schneider Downs Wealth Management Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2019, closing a stake of 25,000 shares — an estimated $13K sold.

Schneider Downs Wealth Management Advisors first reported a position in GCVRZ in Q4 2015 and held it in 15 quarters. The position peaked at $13K in Q2 2019. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2019.

  • Schneider Downs Wealth Management Advisors reported no remaining Sanofi Contingent Value Rights position as of Q3 2019 after selling out during the quarter.
  • Schneider Downs Wealth Management Advisors sold 25,000 Sanofi Contingent Value Rights shares in Q3 2019, an estimated $13K.
  • Schneider Downs Wealth Management Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2015 and held it in 15 quarters.
  • Schneider Downs Wealth Management Advisors's Sanofi Contingent Value Rights position peaked at $13K in Q2 2019.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2019.

Based on Schneider Downs Wealth Management Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.